New AI innovation lab for personalized treatment
Pfizer, AstraZeneca, Merck and Teva have opened AION Labs – a new Israeli innovation lab for startups to develop cutting-edge AI-based technologies for personalized treatments. Startups will use computational biology to discover and develop patient-centric precision medicines.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink